Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Dry Eye Syndrome Market?

Over the past few years, the dry eye syndrome market has been showing robust growth. It is anticipated to increase from $3.92 billion in 2024 to $4.17 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.3%. The significant growth observed in the historical period resulted from factors such as accessibility to healthcare services, advancements in treatment alternatives, availability of medications, health conditions, hormonal fluctuations, and impacts of ocular surgery.

There is an anticipation of robust expansion in the dry eye syndrome market size in the coming years. This market is set to escalate to “$5.51 billion in 2029 with a compound annual growth rate (CAGR) of 7.2%. Various factors such as the aging population, the rise in screen time, changes in lifestyle patterns, increase in health consciousness and accessibility, trends in ocular surgeries, and the emergence of innovative therapies can explain the expected growth during the forecast period. The period is also likely to witness significant trends like the comprehensive approach towards eye health, the application of artificial intelligence in eye care, telemedicine, remote consultations, personalized treatment approach, along with heightened awareness and education.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10704&type=smp

Which Factor Is Shaping The Future Of The Dry Eye Syndrome Market?

The increasing incidence of dry eye syndrome is predicted to fuel the expansion of the corresponding market in the future. Dry eye syndrome, a condition where the eyes fail to generate sufficient tears, is addressed by specific products and medications. These solutions offer lubrication and moisture, enhance tear production, improve tear quality, curtail inflammation, and safeguard the ocular surface. For example, a study by Eyes On Eyecare in March 2022 involving 540 eyecare specialists revealed that about 35 million Americans are set to experience dry eye disease (DED) in 2022, indicating a continually rising trend. Moreover, according to a 2022 meta-analysis of three US studies by UpToDate Inc., a health information firm in the US, the combined prevalence of dry eye was found to be 8.1%. Hence, this surge in dry eye syndrome instances is contributing to the market’s growth.

The dry eye syndrome market covered in this report is segmented –

1) By Product: Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other Products

2) By Treatment: Corticosteroids, Artificial Tears, Oral Omega Supplements, Lubricating Agent, Other Treatments

3) By Disease Type: Evaporative, Aqueous

4) By Distribution Channel: Offline, Online

5) By Application: Hospitals And Clinics, Medical Laboratories, Other Applications

Subsegments:

1) By Liquid Drops: Preservative-Free Drops, Preserved Liquid Drops, Antibiotic-Infused Drops

2) By Gel: Long-Lasting Gels, Hydrogel Formulations

3) By Liquid Wipes: Pre-Moistened Wipes, Anti-Bacterial Wipes

4) By Eye Ointment: Night-Time Ointments, Therapeutic Ointments

5) By Other Products: Eye Masks, Contact Lens Solutions, Nutritional Supplements

Which Emerging Trends And Strategic Shifts Are Shaping The Dry Eye Syndrome Market?

In the dry eye syndrome sector, a leading trend becoming more prevalent is product innovation. In order to maintain their market position, leading firms within the domestic dry eye syndrome industry are creating and introducing new products. For instance, Cyclotears eye drops were introduced in May 2023, by Entod Pharmaceuticals Ltd., a company based in India. These drops are designed specifically for the treatment of dry eye disease. The product leverages self-emulsifying drug delivery system (SEDDS) technology to enhance the delivery of drugs that are not easily soluble in water. The formulation of Cyclotears eye drops uses cyclodextrin, which is aimed to enhance the retention time and stability of the tear film on the surface of the eye. The product claims a unique active ingredient, excellent retention time, a lubricating impact, as well as being safe and free from preservatives.

Which Companies Hold The Largest Market Share In The Dry Eye Syndrome Sector?

Major companies operating in the dry eye syndrome market include Allergan plc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Santendo Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Johnson & Johnson, Alcon Vision LLC, Akorn Operating Company LLC, Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., AbbVie Inc., I-MED Pharma Inc., AFT Pharmaceuticals, Horus Pharma, Mitotech, Novaliq GmbH, OASIS Medical, Prestige Consumer Healthcare, VISUfarma, Alimera Science, Kala Pharmaceuticals Inc., Nicox S.A., EyeGate Pharmaceuticals Inc., ReVision Therapeutics Inc., Itear Medical

https://www.thebusinessresearchcompany.com/report/dry-eye-syndrome-global-market-report

How Does Regional Performance Compare Across The Dry Eye Syndrome Industry?

North America was the largest region in the dry eye syndrome market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global dry eye syndrome market report during the forecast period. The regions covered in the dry eye syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10704&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model